<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="pop_total">0</item><item key="id">3849</item><item key="factors"><item><item key="GSM617134"><item key="DOSE">n/a</item><item key="COMPOUND">Vehicle</item></item></item><item><item key="GSM617134"><item key="DOSE">n/a</item><item key="COMPOUND">Vehicle</item></item></item><item><item key="GSM617136"><item key="DOSE">4mg/kg</item><item key="COMPOUND">CH5424802</item></item></item><item><item key="GSM617136"><item key="DOSE">4mg/kg</item><item key="COMPOUND">CH5424802</item></item></item><item><item key="GSM617138"><item key="DOSE">20mg/kg</item><item key="COMPOUND">CH5424802</item></item></item><item><item key="GSM617138"><item key="DOSE">20mg/kg</item><item key="COMPOUND">CH5424802</item></item></item></item><item key="ownerprofile_id">arrayexpress_sid</item><item key="platform">4</item><item key="summary_wrapped">To clarify the downstream signal pathway of EML4-ALK in NSCLC, we performed Affymetrix GeneChip analysis using ALK inhibitor...</item><item key="pubmed_id">21575866</item><item key="geo_gse_id">E-GEOD-25118</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">2</item><item key="sample_count">6</item><item key="tags"><item>nsclc</item></item><item key="lastmodified">Jun.29, 2015</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">regulation-of-gene-expression-in-alk-inhibitor-ch5</item><item key="geo_id_plat">E-GEOD-25118_A-AFFY-44</item><item key="name">Regulation of gene expression in ALK inhibitor CH5424802-treated NCI-H2228 xenograft tumors</item><item key="created">Sep.15, 2014</item><item key="summary">To clarify the downstream signal pathway of EML4-ALK in NSCLC, we performed Affymetrix GeneChip analysis using ALK inhibitor CH5424802-treated NCI-H2228 xenograft tumors, and comprehensively characterized the gene expression regulated by inhibition of activated ALK. Mice bearing NCI-H2228 cells were orally administered at dose of 0 (vehicle), 4 or 20 mg/kg of CH5424802, and the tumors were collected and lysed at 6 hours post-dose. Total RNA were extracted from xenograft tumors.</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-25118</item><item key="species">human</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-25118/samples/</item></data></biogps>
